America’s Blood Centers, AABB, American Red Cross Joint Letter to CMS Regarding Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare

May 15, 2020

AABB, America’s Blood Centers and the American Red Cross – which collectively represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals – appreciate the Department of Health and Human Services’ ongoing support for the blood community and commend the Centers for Medicare and Medicaid Services (CMS) for developing recommendations for health care…

Read More

America’s Blood Centers, AABB, American Red Cross Joint Letter to HHS Regarding Request for Funding for COVID-19 Convalescent Plasma Collection Reimbursement

May 15, 2020

AABB, America’s Blood Centers and the American Red Cross are requesting funding to pay for COVID-19 convalescent plasma (CCP) that is not otherwise reimbursed. Our organizations – which collectively represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals – are working hard to collect and deliver CCP to patients recovering from COVID-19…

Read More

Reps. McNerney, Engel, Davis & Fitzpatrick Push for Blood Center Relief to Address America’s Blood Shortage

May 1, 2020

Stockton, CA –  As our nation’s blood centers face significant blood donation shortages, growing demand for plasma, and increasing financial strain, Congressman Jerry McNerney (CA-09) co-led a bipartisan letter, along with Representatives Eliot L. Engel (NY-16), Rodney Davis (IL-13), and Brian Fitzpatrick (PA-01), urging House leadership to include assistance for blood centers in the next COVID…

Read More

America’s Blood Centers Partners with BARDA to Expand Collection of Convalescent Plasma for COVID-19 Patients

April 27, 2020

WASHINGTON, April 27, 2020 — America’s Blood Centers and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, are announcing a partnership to further promote collections of COVID-19 convalescent plasma (CCP) from individuals who have recovered from…

Read More

ABC Statement on FDA’s Donor Eligibility Criteria Changes for Men Who Have Sex with Other Men (MSM)

April 24, 2020

America’s Blood Centers and its members are committed to maintaining a safe and available blood supply and treating all potential donors with fairness, equality, and respect. We commend the U.S. Food and Drug Administration (FDA) for their continued support during this unprecedented situation as our nation coordinates response efforts to COVID-19. In recognizing the need…

Read More

America’s Blood Centers, AABB, and the American Red Cross Respond to Request for Public Comments on Section 209 of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

April 10, 2020

AABB, America’s Blood Centers (ABC) and the American Red Cross (ARC) are jointly submitting a response to the request for information (RFI) entitled, “Solicitation for Public Comments on Section 209 of the Pandemic and All-Hazards and Advancing Innovation Act”, which was published in the Federal Register on March 23, 2020. Our organizations are pleased that…

Read More

Community Blood Centers Mobilize to Assist COVID-19 Patients

April 6, 2020

Washington, D.C. (April 6, 2020) – America’s Blood Centers and its members are working closely with the U.S. Food and Drug Administration (FDA) to collect and distribute convalescent plasma from individuals who have recovered from COVID-19. “Community blood centers are at the forefront of delivering convalescent plasma to patients in critical need. This promising investigational…

Read More

Blood Community Unites to Support COVID-19 Patients

April 6, 2020

The U.S. blood community has joined the U.S. Food and Drug Administration and Biomedical Advanced Research and Development Authority in a national effort to support the collection and distribution of convalescent plasma, a potentially life-saving treatment for critically ill COVID-19 patients. While this coronavirus pandemic is unprecedented, the U.S. blood community has a long history…

Read More

ABC Statement on FDA’s Changes to Donor Eligibility Criteria During COVID-19 Pandemic

April 3, 2020

America’s Blood Centers and its members are committed to maintaining a safe and available blood supply and treating all potential donors with fairness, equality, and respect. We commend the U.S. Food and Drug Administration (FDA) for their continued support during this unprecedented situation as our nation coordinates response efforts to COVID-19. In recognizing the need…

Read More

“We Need People to Start Turning Out in Force to Give Blood”

March 12, 2020

 (Washington, DC – March 12, 2020) – “We need people to start turning out in force to give blood.” That urgent call-to-action coming from Peter Marks, M.D., Ph.D., director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research, as fear about the coronavirus is keeping people from wanting to donate…

Read More

Search